Antibody-Drug Conjugates

preview-18
  • Antibody-Drug Conjugates Book Detail

  • Author : Kenneth J. Olivier, Jr.
  • Release Date : 2016-11-14
  • Publisher : John Wiley & Sons
  • Genre : Medical
  • Pages : 567
  • ISBN 13 : 1119060842
  • File Size : 16,16 MB

Antibody-Drug Conjugates by Kenneth J. Olivier, Jr. PDF Summary

Book Description: Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells. • Discusses the basics, drug delivery strategies, pharmacology and toxicology, and regulatory approval strategies • Covers the conduct and design of oncology clinical trials and the use of ADCs for tumor imaging • Includes case studies of ADCs in oncology drug development • Features contributions from highly-regarded experts on the frontlines of ADC research and development

Disclaimer: www.yourbookbest.com does not own Antibody-Drug Conjugates books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Antibody-Drug Conjugates

Antibody-Drug Conjugates

File Size : 44,44 MB
Total View : 9413 Views
DOWNLOAD

Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety a

Antibody-Drug Conjugates

Antibody-Drug Conjugates

File Size : 59,59 MB
Total View : 9373 Views
DOWNLOAD

This volume looks at key methodologies that are commonly used across antibody drug conjugates (ADCs) programs. The chapters in this book cover topics such as co

Antibody-Drug Conjugates

Antibody-Drug Conjugates

File Size : 98,98 MB
Total View : 1676 Views
DOWNLOAD

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal anti